This is clearly evident in patients who suffer from Chronic Granulomatous Disease (CGD) who, because of genetic mutations in the genes encoding the NADPH oxidase, are profoundly susceptible to infection [70]. The gene discussed is FMO5; the disease is chronic granulomatous disease.